'Primary tumour' presentation slideshows

ORAL CAVITY TUMOURS

ORAL CAVITY TUMOURS. DR. JOJO V. JOSEPH MS. MCh (Onco) Chief Cancer Surgeon and Oncologist Division of Oncology Caritas Hospital, Thellakom, Kottayam. CANCERS OF ORAL CAVITY. High Incidence Easy to treat Metastasis Good results Field Cancerisation Improper treatment - MISERABLE LIFE.

761 views • 55 slides

Orde in de volgorde bij synchrone levermetastasen bij een colorectaal carcinoom

Orde in de volgorde bij synchrone levermetastasen bij een colorectaal carcinoom. Pieter Tanis, chirurg Academisch Medisch Centrum, Amsterdam. Mulitmodality treatment stage IV CRC. Synchronous CRCLM. Cure. Radiotherapy. Chemotherapy. Surgery. Local ablation Stereotactic RTx SIRT.

406 views • 40 slides

Cancer?

Cancer?. National Cancer Institute Artwork J Kelly 2004. Learning Objectives To gain a greater understanding of cancer To be aware of some of the common cancers To have a greater understanding of the diagnostic process. Incidence of Cancer (2009). Top 10 Cancers in Males.

467 views • 32 slides

When should we consider liver first approach in synchronous colorectal liver metastasis?

When should we consider liver first approach in synchronous colorectal liver metastasis?. Tommy Yip Siu-man Prince of Wales Hospital. Introduction. Colorectal cancer is the third most common cancer worldwide 1 ~25 % of patients have synchronous liver metastases at the time of diagnosis 2

738 views • 30 slides

Value of local treatment in extrapulmonary metastatic Ewing sarcoma

412 views • 22 slides

Value of local treatment in extrapulmonary metastatic Ewing sarcoma

364 views • 22 slides

LUNG CANCER

LUNG CANCER. * Carcinoma of the lung is the leading cause of cancer death in USA. * 171900 new cases in 2003=12.8% of total new cases. *5-year survival rate for the lung remains 14% in USA,8%in China and Europe.

190 views • 19 slides

Discordance in hormone receptor status in breast cancer during tumour progression

265 views • 17 slides

Testicular cancer: current views

Testicular cancer: current views. Dr. M. Mangala MD (Kin); FRCS (Ireland); MMed (Wits); FCS (SA) Urology 38 th BMA CONGRESS. Background. 1% and 1.5% male neoplasms 5% all urological tumors Prevalence 2-3/100000 In the 15-34 y.o 62/100000 5% cases bilateral

482 views • 17 slides

DEBIRI TACE Patterns and Predictors of Response

DEBIRI TACE Patterns and Predictors of Response. Robert Jones. Declaration Robert Jones is a consultant to Biocompatibles UK LTD. Pathological response to chemotherapy predicts survival. 100 90 80 70 60 50 40 30 20 10 0. Complete response. % survival. Major response. Minor

679 views • 15 slides

BRONCHOIAL TUMOURS

216 views • 12 slides

Dr Simon Brewster, Churchill Hospital, Oxford, UK

ESOU Challenging the EAU Guidelines Debate: Stage 1 Non- seminomatous germ cell tumours of the testis should all be managed by Surveillance. Dr Simon Brewster, Churchill Hospital, Oxford, UK. Introduction.

203 views • 10 slides

Table 2 Studies comparing HER2 status in the primary tumour and in CTCs

Table 2 Studies comparing HER2 status in the primary tumour and in CTCs. De Mattos-Arruda, L. et al. ( 2013) Circulating tumour cells and cell-free DNA as tools for managing breast cancer Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2013.80.

116 views • 1 slides

L Ding et al . Nature 000 , 1 - 5 (2012) doi:10.1038/nature10738

Graphical representation of clonal evolution from the primary tumour to relapse in UPN 933124, and patterns of tumour evolution observed in eight primary tumour and relapse pairs. L Ding et al . Nature 000 , 1 - 5 (2012) doi:10.1038/nature10738.

210 views • 1 slides